Meyers Michael L. 4
4 · Syndax Pharmaceuticals Inc · Filed Jul 8, 2020
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Award
Common Stock
2020-07-06+3,500→ 10,730 total
Footnotes (1)
- [F1]50% of the shares will vest on July 6, 2021 and the remaining 50% of the shares will vest on July 6, 2022.